Wall Street researchers just used Claude to design a drug. The experiment has spawned a new investment thesis.

For years, artificial-intelligence evangelists have boasted about the technology’s capacity to revolutionize drug development and medical research.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketwatch.com)